Foreign takeovers of London-listed companies are continuing as low valuations and international business exposure keep attracting overseas buyers. The trend is intensifying at a time when only ...
Foreign takeovers of London-listed companies continue to gather pace as overseas buyers target UK groups with lower valuations and international operations. In that backdrop, Swiss engineering ...
Heightened U.S. scrutiny of China's biotechnology sector is widening to pharmaceutical research, as House lawmakers investigate whether clinical trials by Merck and AbbVie in China create ethical ...